Cargando…
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here, we report the cryo-EM...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519878/ https://www.ncbi.nlm.nih.gov/pubmed/34706271 http://dx.doi.org/10.1016/j.celrep.2021.109928 |
_version_ | 1784584546588557312 |
---|---|
author | Cerutti, Gabriele Guo, Yicheng Wang, Pengfei Nair, Manoj S. Wang, Maple Huang, Yaoxing Yu, Jian Liu, Lihong Katsamba, Phinikoula S. Bahna, Fabiana Reddem, Eswar R. Kwong, Peter D. Ho, David D. Sheng, Zizhang Shapiro, Lawrence |
author_facet | Cerutti, Gabriele Guo, Yicheng Wang, Pengfei Nair, Manoj S. Wang, Maple Huang, Yaoxing Yu, Jian Liu, Lihong Katsamba, Phinikoula S. Bahna, Fabiana Reddem, Eswar R. Kwong, Peter D. Ho, David D. Sheng, Zizhang Shapiro, Lawrence |
author_sort | Cerutti, Gabriele |
collection | PubMed |
description | Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here, we report the cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hydrophobic pocket between the two sheets of the NTD β sandwich. Interestingly, this pocket was previously identified as the binding site for hydrophobic molecules, including heme metabolites, but we observe that their presence does not substantially impede 5-7 recognition. Mirroring its distinctive binding, antibody 5-7 retains neutralization potency with many variants of concern (VOCs). Overall, we reveal that a hydrophobic pocket in NTD proposed for immune evasion can be used by the immune system for recognition. |
format | Online Article Text |
id | pubmed-8519878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). |
record_format | MEDLINE/PubMed |
spelling | pubmed-85198782021-10-18 Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain Cerutti, Gabriele Guo, Yicheng Wang, Pengfei Nair, Manoj S. Wang, Maple Huang, Yaoxing Yu, Jian Liu, Lihong Katsamba, Phinikoula S. Bahna, Fabiana Reddem, Eswar R. Kwong, Peter D. Ho, David D. Sheng, Zizhang Shapiro, Lawrence Cell Rep Report Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here, we report the cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hydrophobic pocket between the two sheets of the NTD β sandwich. Interestingly, this pocket was previously identified as the binding site for hydrophobic molecules, including heme metabolites, but we observe that their presence does not substantially impede 5-7 recognition. Mirroring its distinctive binding, antibody 5-7 retains neutralization potency with many variants of concern (VOCs). Overall, we reveal that a hydrophobic pocket in NTD proposed for immune evasion can be used by the immune system for recognition. The Author(s). 2021-11-02 2021-10-16 /pmc/articles/PMC8519878/ /pubmed/34706271 http://dx.doi.org/10.1016/j.celrep.2021.109928 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Report Cerutti, Gabriele Guo, Yicheng Wang, Pengfei Nair, Manoj S. Wang, Maple Huang, Yaoxing Yu, Jian Liu, Lihong Katsamba, Phinikoula S. Bahna, Fabiana Reddem, Eswar R. Kwong, Peter D. Ho, David D. Sheng, Zizhang Shapiro, Lawrence Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title_full | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title_fullStr | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title_full_unstemmed | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title_short | Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
title_sort | neutralizing antibody 5-7 defines a distinct site of vulnerability in sars-cov-2 spike n-terminal domain |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519878/ https://www.ncbi.nlm.nih.gov/pubmed/34706271 http://dx.doi.org/10.1016/j.celrep.2021.109928 |
work_keys_str_mv | AT ceruttigabriele neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT guoyicheng neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT wangpengfei neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT nairmanojs neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT wangmaple neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT huangyaoxing neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT yujian neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT liulihong neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT katsambaphinikoulas neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT bahnafabiana neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT reddemeswarr neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT kwongpeterd neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT hodavidd neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT shengzizhang neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain AT shapirolawrence neutralizingantibody57definesadistinctsiteofvulnerabilityinsarscov2spikenterminaldomain |